This is a women's world
We envision the XXI century as a time when women will immensely contribute to a more peaceful and equitable society, as they will continue to assume more and more top responsibilities in corporations, world affairs, and society at large.
We at Womed aim to support women in this historical evolution by offering them better care for their specific health needs, which have traditionally been low research priorities.
Gonzague Issenmann
Chairman
The Women of Womed
Womed was born and has been growing with the support of a constellation of women stars who share our common mission and encourage our endeavors on a daily basis. We are very grateful to them and wish to honor them for their hard work and dedication.
Co founders
Stephanie Huberlant, PhD
Medical consultant
Obstetric and Gynecology surgeon,
Reproductive Specialist
CHU Carémeau, France
Gonzague Issenmann
Chairman
Health tech entrepreneur
Previously co-founder and CEO of STENTYS
MBA INSEAD and MSc Ecole Centrale Paris
Xavier Garric, PhD
Scientific consultant
Pharmacist and specialist in polymers for drug delivery systems
Director of the Polymers for Health and Biomaterials Department (IBMM), University of Montpellier, France
Medical advisors
Hervé Fernandez, MD, PhD
Director of gynaecology and obstetrics department at Kremlin Bicêtre, Paris, France
Keith Isaacson,
MD
Director of Minimally Invasive Gynecologic Surgery and Infertility,
Newton Wellesley Hospital, USA
Associate Professor of Obstetrics and Gynecology
Andreas Thurkow,
MD
Gynaecology surgeon specialized in minimal invasive surgery at Bergman Clinics, Amsterdam and affiliated with the Amsterdam University Medical Centres, the Netherlands
Angelo Hooker,
MD
Obstetrics and gynaecology surgeon at Zaans medical center, the Netherlands
History
Womed stems from research conducted at Pr Garric's biopolymer lab at the University of Montpellier, France, and which aimed at finding an elegant solution to an unmet medical need in gynecologic surgery: intrauterine adhesions. The research project started in 2013 and was conducted as the thesis work of several PhD students. At the conclusion of the thesis in 2018, Womed SAS was spun off to make the invention available to millions of women around the world, and expand the use of the technology to multiple uterine indications.
Womed is dedicated to quality and is ISO 13485 certified.